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Case reports: “Explaining the phenomena of clinical experience3” “A cornerstone
of medical progress11”1. Introduction and background
There is increasing realisation that no single method of obtain-
ing and marshalling evidence about what is already known about
a healthcare intervention will not, on its own, provide us with all
the information and insight we need in order to be able to care as
well as we might for people who are ill. ‘Evidence-based medicine’
(EBM) in the shape of the randomized controlled clinical trial (RCT)
frequently described as the gold standard of obtaining evidence,
was for some time placed on the pinnacle, overshadowing all other
methods. Those who attempted to criticize or explore that notion
were shot down. That time is past.
Defending dearly held beliefs and dogmas in the face of ques-
tioning or criticism about a particular class of evidence is not the
route to enlightenment or improvement of the status quo. As
recently as October 2008, Professor Sir Michael Rawlins Harveian
Oration,1 ‘De Testimonio’, was headlined in a Royal College of Physi-
cians’ news item2 as an ‘attack on traditional ways of assessing the
evidence of therapeutic interventions’. Sir Michael’s belief was that
arguments about the relative importance of different kinds of
evidence are an unnecessary distraction. He thought that what is
needed instead is for “investigators to continue to develop and
improve their methodologies; for decision makers to avoid adopt-
ing entrenched positions about the nature of evidence; and for
both to accept that the interpretation of evidence requires judge-
ment”. This broader, more questioning view opened up this more
ﬂexible approach to the worth of different kinds of evidence for
debate and consideration. It encourages health practitioners to
dare to break out of the regulatory boxes and look further than
guidelines to use their clinical experience3 and critical faculties,
and develop their sleuthing skills. As Rawlins suggests, distinguish-
ing the iatrogenic from the intercurrent and non-causal statistically
signiﬁcant adverse events that are observed in RCTs, or those that
are just random error, is as much an art as a science. In this spirit,
Agha and Rosin describe their editorial as an ‘open call to the Sher-
lock Holmes within us’ and invite readers to join in their exciting
new IJSCR venture.4
It might be thought that recent serious attempts to draw strands
together, or to challenge theplace of evidence-basedmedicine in the
hierarchy, or to attempt to integrate qualitative with quantitative
evidence,5 or utilise other types of evidence, is something new:
this is not so. Even in18th centuryBritain, asUlrich Tröhlerdescribes
in theopeningchapterof his book “To improve theevidenceofmedi-
cine”, there was a desire to bridge the age-old schism between the
dogmatist’s and empiricist’s ‘way to truth’. As he explains, by1743-9191/$ – see front matter  2010 Surgical Associates Ltd. Published by Elsevier Lt
doi:10.1016/j.ijsu.2010.05.001pursuing independent agendas, dogmatists and empiricists had
failed to develop a shared framework for obtaining and interpreting
reliable evidence. Tröhler, bearing inmind the efforts that have been
made in the last half-century in particular, is optimistic, believing
that students, clinicians and patients, together with policy-makers,
are taking account of the cumulative results of relevant research
about health care.6 Case reports are one of those strands that need
tobewoven in toourappraisal of healthcare inourefforts to improve
what we offer to patients and the public.
2. Pros and cons
All ‘interventions’ have pros and cons: case reports are no excep-
tion.7 IainChalmers, inhis commentpiece ‘Cases Journal should follow
Venning’s quarter-century old example’ on Richard Smith’s editorial:
Why do we need Cases Journal?,8 strikes a cautionary note: “Case
reports can indeed lead to improved care of patients; but it is impor-
tant to remember that they can also be lethal”.9 Hewiselywarns that
impressions about the effects of care are sometimes right, and some-
timeswrong: validated case reports can lead to improvements in the
care of patients; invalid case reports can kill them.
He counters Richard Smith’s suggestion (who quotes from Enkin
and Jadad10) that randomized trials “should be taken off their
pedestal” with a couple of cautionary tales from Enkin (long term
adverse consequences of fetal exposure to corticosteroids; use of
diethylstilboestrol (DES) in pregnancy).
He concludes that “informal evaluation of care based on impres-
sions, and formal evaluation based on well-controlled comparisons
of alternative forms of care, both play essential roles in the promo-
tion of more effective care during pregnancy and childbirth”.
3. Good quality reporting
To assist authors of reports of observational studies, the Equator
Network has published the STROBE Statement of guidelines: www.
equator-network.org/index.aspx?o¼1032 STROBE stands for an
international, collaborative initiative of epidemiologists,
methodologists, statisticians, researchers and journal editors
involved in the conduct and dissemination of observational
studies, with the common aim of STrengthening the Reporting of
OBservational studies in Epidemiology. The latest version,
Published 2007, shows checklists for four types of observational
studies, but there currently is no published guideline available for
case reports: authors of case reports are advised to follow
journal’s instructions.d. All rights reserved.
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beneﬁcial role that case reports can play in furtheringmedical prog-
ress, he emphasised the need for good quality reporting. He wrote:
“Case reports and case series have their own rôle in the progress
of medical science. They permit discovery of new diseases and
unexpected effects (adverse or beneﬁcial) as well as the study of
mechanisms, and they play an important role in medical
education. Case reports and series have a high sensitivity for
detecting novelty and therefore remain one of the cornerstones
of medical progress; they provide many new ideas in medicine.
At the same time, good case reporting demands a clear focus to
make explicit to the audience why a particular observation is
important in the context of existing knowledge”.11
Austin Bradford Hill, statistician and the pioneer of fair tests of
treatments, said that those reading research reports of clinical trials
would need to know answers to certain questions. Those reading
case reports will certainly want to know “What did you ﬁnd?”
They should also be led to consider: “What does/(might) it mean
anyway?” – and why the observation is important in the context of
existing knowledge. Impressions formed from case reports need to
be followedupby formal investigations: dangerariseswhen impres-
sions alone are used to guide treatment recommendations.12
Vandenbrouke gives particular advice about writing a good case
report.9 His ﬁrst, most important rule is that the author must be
very clear about the single message s/he wants to bring. He then
lists some other questions that the author should consider:
 Why, exactly is this particular observation important?
 What does it teach us?
 Does it run counter to some particular cherished truth? If so,
spell out this truth and explain to the reader how and why it
is contradicted.
 Does it strike the “prepared mind”? If so, explain what the
background ideas were and how this observation ﬁts and
extends the background idea.
 Is it an unexpected association? Then describe what the expec-
tation was, even if only in terms of very crude numbers.
 Was it an “elicited observation” to study a mechanism? He
instructs the author to tell the reader what was elicited and
why, and whether one can generalise the mechanism.
 Is it a rarity that would otherwise be missed? If so, state explic-
itly how and why it could be missed.
Vandenbrouke advises that the writer (or narrator) should lay
bare his or her thought process, as crisply and pointedly as possible,
because that is the only way to impress and strike a chord with the
reader. He goes on to say that the usual IMRAD format (Introduc-
tion, Method, Results and Discussion) might not always be appro-
priate for case reports and case series.
He concludes:
“Last but not least, case reporting for medical education or for
medical research is great fun. Like much of medical reasoning, it
has a detective-like quality. It brings a smile of recognition, or of
satisfactory understanding, to the faces of the presentator [sic]
and audience. The temporary fall from favour of this classic type
of medical literature may prove to have been the best remedy
for its ultimate survival”.4. Adverse effects; patient safety
Rawlins has warned of the problems of both probity and science
in the assessment of safety from randomized controlled trials. RCTs
are more likely to detect dramatic harms, but they are an unreliableapproach to the deﬁnite identiﬁcation of harms, even though it is
now customary to collect and record all of the adverse effects occur-
ring after randomisation. Whilst they may identify the more
common reactions, they often fail to recognise the less common
ones.3 It is here that case reports have a distinct role to play.
A systematic review was undertaken in Spain covering a period
from January 1990 to December 1999. The researchers found that
during that period, a total of 22 drugs had been withdrawn from
the market for safety reasons. In 18 of 22 cases (82%) the evidence
supporting the drug withdrawal came from individual case reports,
case series, or the combination of data provided by randomized
clinical trials and case reports. They concluded:
“Case reports are the main source of information used to
withdraw a drug from the market for safety reasons. It is
necessary to improve the quality of evidence supporting the
withdrawal process of drugs linked to unexpected and severe
adverse drug reactions (ADRs). The use of large databases to
perform cohort or nested case-control analyses is the most
efﬁcient and reliable method to study type-A class effect ADRs.
The implementation of such databases in different countries
could increase the quality of the information on ADRs by
allowing researchers to conduct efﬁciently these type of
studies”.13
This efﬁciency of a large database to perform a nested case-
control study is demonstrated in a study set up ‘to evaluate if the
prostate speciﬁc antigen test attains validity standards required for
screening in view of prostate cancer screening trial results’. The
main outcome measure was validity of prostate speciﬁc antigen
(PSA) for prediction of subsequent prostate cancer diagnosis by
record linkage to a cancer registry. Participants were 540 cases and
1034 controls matched for age and date of blood draw. The
researchers concluded thatno single cut-off value for PSAconcentra-
tionattained likelihood ratios formally requiredbya screening test.14
In a personal communication, (e-mail 16th April 2010) Amanda
Burls, Director of Postgraduate Programmes in Evidence-Based
HealthCare (EBHC) at the University of Oxford, commenting on
this study, opined that this research must have cost a tiny fraction
of what the trials have cost to date, but, had it been done earlier,
may have pre-empted trials being done in the ﬁrst place and large
sums ofmoney beingwasted for a predictable result. She suggested
that more training in clinical epidemiology could be important for
health researchers or funders of health research.
It is important to remember that when patients and their
doctors are attempting to make decisions about treatments, or
when members of the public are attempting to make decisions
about undergoing diagnostic or prophylactic/preventive options,
they need to know about potential harms as well as about any
beneﬁts that might accrue. Many of these screening/testing deci-
sions require to be made later in life – a time when many people
may have a variety of co-morbidities – where evidence from RCTs
is not always completely helpful.5. Source of research questions
A database of case-control studies would provide a resource to
identify unanswered research questions that are of particular
importance to patients.6. What rôles for patients and public?
Patients can provide the encouragement for the tolerance of
different kinds of scientist: the collectors, classiﬁers and compul-
sive tidiers-up; those with the temperaments of detectives or of
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philosophers–scientists and the mystic.15
Patients and members of the pubic have a valuable rôle to play
by being alert to unusual side effects and taking constructive steps
to bring them to notice. There could be considerable value in case
reports jointly authored by patient and clinician, whichmight illus-
trate the value of a free and equal exchange of dialogue, not just
within that relationship, but taken forward in a case report for
publication and wider consideration. The responsibility for sleuth-
ing does not rest solely with the profession!
7. Conclusion
The time is now right for a new approach to better use of case
reports,4 time for us all to experience the fun11 of contributing to
the venture. As with “medical arithmetic and experimentation” in
late 18th century Britain, the “numerical method” in 1830s Paris of
Pierre-Charles-Alexandre Louis, or “clinical epidemiology” and
“evidence-based medicine” in our era, evaluation of medical inter-
ventions depends on an appropriate climate to be able to grow and
become credible.6 We now have not only the ways and means of
assembling a well-organised database of case reports, but also
enthusiasm for doing so.4 There is recognition that when judicially
selected, well-written, published and used, case reports can provide
avaluable resource bringing colour andbreathing life in to the strong
framework of quantitative systematically-reviewed evidence that
we are in the process of assembling for the beneﬁt of patients.
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